Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
screening for reproductive / developmental toxicity
Remarks:
based on test type (migrated information)
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
2012
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Rationale for read-across: naphthenic acid is presumed to be the toxic metabolite of NA-DETA Rationale for assigning reliability of 2: read-across, scientifically well performed study

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
GLP compliance:
yes (incl. QA statement)
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Naphthenic acids
EC Number:
215-662-8
EC Name:
Naphthenic acids
Cas Number:
1338-24-5
Molecular formula:
"CnH2n+zO2, where n = carbon number and z = homologous group series number: z = 0 when no ring structures are present, z = -2 when 1 ring is present, z = -4 when 2 rings are present etc Result of high resolution mass spectroscopy of 4 naphthenic acids samples from different suppliers/sources: Ring distribution of aliphatic fraction: Z = 0 15-30% Z = -2 35-50% Z = -4 10-25% Z = -6 1-7% Z = -8 0-2% Z <= -6 1-5% (unsaturated compounds) Z >= -8 0-2% (unsaturated compounds) C<= 18 8-15% (N-containing compounds) C > 18 0-2% (N-containing compounds) Unknown 0-2% Distribution of carbon number (n) of 4 naphthenic acids samples from different suppliers/sources (n):C4-C27 (main: C8-C20)
IUPAC Name:
Naphthenic acids
Test material form:
other: oily liquid
Details on test material:
Blend of naphthenic acids from three sources.

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
Male dosing was for 28-29 days
Females were dosed for 39-53 days
Frequency of treatment:
daily
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 100, 300, 900 mg/kg bw
Basis:
actual ingested
No. of animals per sex per dose:
12
Control animals:
yes, concurrent vehicle

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
unspecific toxic signs in females of 900 mg/kg bw
Body weight and weight changes:
no effects observed
Description (incidence and severity):
no statistically significant effect
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
no statistically significant effect
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Histopathological findings: non-neoplastic:
effects observed, treatment-related
Description (incidence and severity):
alterations found in liver, kidney, thyroid, thymus and adrenal

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
no effects observed
Reproductive function: sperm measures:
no effects observed
Reproductive performance:
no effects observed

Effect levels (P0)

Dose descriptor:
NOAEL
Effect level:
100 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: overall effects

Results: F1 generation

General toxicity (F1)

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
reduced survival of pubs from birth to lactation day 4
Mortality / viability:
mortality observed, treatment-related
Description (incidence and severity):
reduced at 900 mg/kg bw
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
reduced for pubs of 900 mg/kg bw
Sexual maturation:
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Histopathological findings:
not examined

Effect levels (F1)

Dose descriptor:
NOAEL
Generation:
F1
Effect level:
100 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: Number of pubs born; Percentage of pups surviving from birth to termination PND 4

Overall reproductive toxicity

Reproductive effects observed:
not specified

Any other information on results incl. tables

Parental toxicity data:

Table 1. Results of Assessments of hematology and clinical chemistry parameters which were statistically different from control values.1

Parameter Measured

Corn Oil Control

100 mg/kg/day

300 mg/kg/day

900 mg/kg/day

Males, data taken at terminal sacrifice

Red Blood Cell Count (106/ul)2

9.22 ± 0.54

9.28 ± 0.28

8.91 ± 0.34

8.78 ± 0.22*

Hemoglobin (g/dL)2

15.7 ± 0.72

15.8 ± 0.48

15.2 ± 0.54

14.7 ± 0.44*

Hematocrit (%)2

48.1 ± 2.4

48.6 ± 1.6

46.5 ± 1.5

45.0 ± 1.8**

Platelet (103/ul)2

854 ± 151

885 ± 84

803 ± 144

976 ± 87**

Leukocytes, absolute (103/ul)2

0.02 ± 0.02

0.03 ± 0.02

0.02 ± 0.02

0.04 ± 0.03*

RDW (%)2

11.4 ± 0.4

11.5 ± 0.4

11.6 ± 0.4

12.5 ± 0.6**

HDW (g/dL)2

2.58 ± 0.10

2.68 ± 0.12

2.76 ± 0.16*

2.77 ± 0.27*

Females, data taken at termination (lactation day 4)

White blood cell count2

5.15 ± 1.30

6.89 ± 1.58

7.68 ± 2.24*

7.59 ± 1.85*

APTT (seconds)2

16.8 ± 1.9

15.9 ± 2.3

15.8 ± 3.1

13.9 ± 1.4 *

Lymphocytes, absolute (103/ul),

3.32 ± 0.61

4.50 ± 1.42

5.11 ± 1.75*

4.96 ± 1.60*

Monocytes, absolute (103/ul)

0.11 ± 0.10

0.24 ± 0.21

0.21 ± 0.12

0.35 ± 0.23*

 

1. Parameters not affected by treatment included:

a. Males – white blood cell count, mean corpuscular volume (fL), mean corpuscular hemoglobin (pg), mean corpuscular hemoglobin content (g/dL), prothrombin time (sec), APTT (sec), reticulocytes (%), reticulocytes, absolute (103/ul), MPV (fL), neutrophils (%), lymphocytes (%), monocytes (%), eosinophils (%), basophils (%), leucocytes(%), neutrophils, absolute (103/ul), lymphocytes, absolute (103/ul), monocytes, absolute (103/ul), eosinophils, absolute (103/ul), basophils, absolute (103/ul).

b. Females – red blood cell count (106/ul), Hemoglobin content (g/dL), hematocrit (%), mean corpuscular volume (fL), mean corpuscular hemoglobin (pg), mean corpuscular hemoglobin content (g/dL), platelet count (103/ul), prothrombin time (sec), reticulocytes (%), reticulocytes, absolute (103/ul), ), MPV (fL), neutrophils (%), lymphocytes (%), monocytes (%), eosinophils (%), basophils (%), leucocytes(%), neutrophils, absolute (103/ul), eosinophils, absolute (103/ul), basophils, absolute (103/ul), Leukocytes absolute (103/ul), RDW (%), HDW (g/dL)

 

2. Data given as mean + SD

* = p < 0.05, ** = p < 0.01


 

Table 2. Statistically significant changes in terminal body weights and organ weights.The data are given as mean + SD.

Parameter

Sham Control

Corn Oil Control

100 mg/kg/day

300 mg/kg/day

900 mg/kg/day

Males

Final Body Weight

467 ± 27

454 ± 45

448 ± 45

439 ± 34

412 ± 28

Liver

15.61 ± 1.43

13.46 ± 2.01

13.98 ± 2.04

15.69 ± 1.83*

19.94 ± 2.08**

Kidney

3.51 ± 0.25

3.21 ± 0.20*

3.38 ± 0.39

3.53 ± 0.33

3.77 ± 0.46**

Heart

1.46 ± 0.09

1.46 ± 0.21

1.41 ± 0.14

1.43 ± 0.13

1.32 ± 0.13

Thyroid/parathyroid

0.019 ± 0.002

0.019 ± 0.001

0.020 ± 0.002

0.020 ± 0.002

0.020 ± 0.002

Epididymis (LT)

0.57 ± 0.14

0.60 ± 0.05

0.60 ± 0.04

0.66 ± 0.05*

0.63 ± 0.06

Epididymis (RT)

0.62 ± 0.04

0.62 ± 0.06

0.61 ± 0.03

0.66 ± 0.04

0.65 ± 0.06

Females

Final body Weight

335 ± 25

313 ± 23

301 ± 30

294 ± 24

289 ± 24

Liver

13.6 ± 2.0

11.7 ± 1.5

12.1 ± 1.1

13.3 ± 1.5

17.9 ± 2.4**

Kidney

2.39 ± 0.17

2.07 ± 0.18*

2.11 ± 0.15

2.05 ± 0.25

2.17 ± 0.19

Heart

1.21 ± 0.23

1.10 ± 0.10

1.08 ± 0.10

1.07 ± 0.11

1.01 ± 0.13

Lungs

1.36 ± 0.13

1.40 ± 0.13

1.26 ± 0.12*

1.20 +± 0.12**

1.20 ± 0.07**

Uterus/Vagina

1.07 ± 0.19

1.00 ± 0.14

0.86 ± 0.08*

0.88 ± 0.11*

0.85 ± 0.12*

* = p < 0.05, ** = p < 0.01

 


Table 3. Summary of microscopic findings

Doses, mg/kg/day

Males

Females

Corn Oil

100

300

900

Corn Oil

100

300

900

N

12

12

12

12

9

12

10

10

Kidney

Hyaline Droplets

0

3

10**

11**

0

0

0

0

Minimal

0

3

9**

9**

0

0

0

0

Mild

0

0

1

2

 

 

 

 

 

 

 

 

 

 

 

 

 

Nephropathy

0

0

2

9**

0

0

0

0

Minimal

0

0

2

5*

0

0

0

0

Mild

0

0

0

4

 

 

 

 

 

 

 

 

 

 

 

 

 

Liver

 

 

 

 

 

 

 

 

Hypertrophy, hepatocellular, centrilobular

0

0

0

8**

0

0

0

10**

Minimal

0

0

0

8**

0

0

0

10**

 

 

 

 

 

 

 

 

 

Vacuolation, hepatocellular

2

1

2

0

0

1

0

2

Minimal

1

1

2

0

0

1

0

2

Mild

1

0

0

0

0

0

0

0

 

 

 

 

 

 

 

 

 

Thymus

 

 

 

 

 

 

 

 

Depletion, lymphoid, cortex

0

0

0

0

0

1

0

5

Minimal

0

0

0

0

0

1

0

4

Mild

0

0

0

0

0

0

0

1

 

 

 

 

 

 

 

 

 

Thyroid

 

 

 

 

 

 

 

 

Hypertrophy, epithelial

0

6

9*

11**

0

3

4

8**

Minimal

0

6

9**

11**

0

3

4

6*

Mild

0

0

0

0

0

0

0

2

 

 

 

 

 

 

 

 

 

Vacuolation, cytoplasmic

0

6

9**

10**

0

3

4

8**

Minimal

0

6

9**

10**

0

3

4

8**

 

 

 

 

 

 

 

 

 

Adrenal Cortex

 

 

 

 

 

 

 

 

Vacuolation, cytoplasmic

0

2

3

2

0

0

0

2

Minimal

0

2

3

2

0

0

0

1

Mild

0

0

0

0

0

0

0

1

 

 

 

 

 

 

 

 

 

Heart

 

 

 

 

 

 

 

 

Cardiomyopathy

 

 

 

 

 

 

 

 

 

Minimal

4

7

8*

8*

3

3

2

5

Mild

2

0

0

0

0

0

0

0

* = p < 0.05, ** = p < 0.01

Data on reproduction performance and offsprings

Table 1. Summary of reproductive parameters assessed in the repeated dose/reproductive toxicity study of naphthenic acids.

Dose (mg/kg bw)

Corn Oil Control

100 mg/kg/day

300 mg/kg/day

900 mg/kg/day

Number of females paired

12

12

12

12

Number of females mated

12

12

10

11

Number of females pregnanta

9

12

10

11

Number of females with litters

9

12

10

11

Precoital interval (days)

1.4 ± 0.7

2.3 ± 1.1

4.2 ± 3.3 *b

3.8 ± 3.5

Gestation length (days)

21.4 ± 0.6

21.9 ± 0.3

22.0 ± 0.5

22.1 ± 0.5

Corpora lutea

15.6 ± 2.3

14.0 ± 1.4

15.1 ± 3.0

13.8 ± 2.1

Implantation sites

15.0 ± 2.4

13.6 ± 1.1

13.0 ± 1.2

12.2 ± 3.7

Number born

14.1 ± 1.9

12.9 ± 1.1

12.0 ± 1.6

10.8 ± 3.8 *

Post-implantation loss (%)

6.0

5.1

7.7

11.5

 

a. Pregnant = uterine implantation sites

b. A single female in the 300 mg/kg bw group had a pre-coital interval of 13 days

 

* = p < 0.05, ** = p < 0.01

Table 2. Survival, viability and growth of offspring

 

Dose (mg/kg bw)

Corn Oil Control

100 mg/kg/day

300 mg/kg/day

900 mg/kg/day

Number of viable litters

9

12

10

11

Number of pubs born alive/litter

13.9 ± 1.9

12.9 ± 1.1

10.1 ± 4.0 *

9.6 ± 4.0 **

Percentage of pubs surviving from birth to PND 4

98.1 ± 3.8

100 ± 0.0

88.0 ± 24.5

67.7 ± 40.6

Pubs (litters) found dead or euthanized in extremis

1(1)

0(0)

12(5)

38(8)

Sex ratio (% males / litter)

58.9 ± 9.6

53.9 ± 9.6

55.2 ± 19.1

58.1 ± 22.7

Pub weight PND 1 -males

7.0 ± 0.5

6.7 ± 0.6

6.7 ± 0.5

5.7 ± 0.8 *

Pub weight PND 1 -females

6.6 ± 0.6

6.5 ± 0.6

6.4 ± 0.4

5.6 ± 1.1

Pub weight PND 4 -males

9.7 ± 1.1

9.4 ± 1.2

9.4 ± 0.9

7.2 ± 1.5 **

Pub weight PND 4 -females

9.1 ± 1.0

9.0 ± 1.0

8.8 ± 0.7

7.3 ± 1.5 **

 

* = p < 0.05, ** = p < 0.01

Applicant's summary and conclusion

Conclusions:
The commercial naphthenic acid was investigated for its reproduction toxicity according to the OECD Guideliine 422. The NOAEL was 100 mg/kg bw both for parental and offsprings. The introduced study is proposed to be used to derive the reproduction toxicity of NA-DETA by read-across.
Executive summary:

The commercial naphthenic acid was investigated for its repeated dose toxicity according to the OECD Guideline 422. The applied doses were 0, 100, 300 and 900 mg/kg bw.

All animals survived to scheduled termination except two females of 900 mg/kg bw group. The terminal body weight of males and females of 900 mg/kg bw were reduced. Reduced red blood cell count for males of 900 mg/kg bw and increased white blood cell count for females of 900 and 300 mg/kg bw were observed. Liver weight was increased for animals of 900 mg/kg bw and kidney weight was increased for males only in this group. The histopathological findings comprised hepatocellular hypertrophy, hyaline-droplet nephropathy, cortial lymphoid depletion in thymus, epithelial hypertrophy and cytoplasmic vacuolation of the thyroid gland and cytoplasmic vacuolation in the adrenal cortex. The NOAEL was 100 mg/kg bw for parental animals.

With respect to the reproductive/developmental toxicity investigation, reduced live pubs at birth and reduced survival rate from birth to PND 4 was found at doses of 300 and 900 mg/kg bw and reduced pub weights at dose of 900 mg/kg bw. The NOAEL for reproductive/developmental toxicity was 100 mg/kg bw. 

The introduced study is proposed to be used to derive the reproduction toxicity of NA-DETA by read-across.